Navigation Links
Pancreatic Cancer Action Network and AACR award research grants totaling nearly $3 million
Date:3/25/2011

ORLANDO, Fla. The Pancreatic Cancer Action Network and the American Association for Cancer Research awarded 10 grants to outstanding scientists throughout the country, supporting their innovative research in the field of pancreatic cancer. This year's total funding level of nearly $3 million represents the largest annual disbursement since the Pancreatic Cancer Action Network introduced the program in 2003. The recipients will be honored at a recognition event scheduled during the AACR 102nd Annual Meeting 2011, held April 2-6, at the Orange County Convention Center in Orlando, Fla.

"These grants are crucial to promoting ongoing impactful pancreatic cancer research," said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. "They encourage both young and experienced researchers to collaborate in an effort to make innovative breakthroughs to beat this devastating disease."

"This year's grants program marks a significant milestone over $10 million in research funding awarded by the Pancreatic Cancer Action Network since our program's inception eight years ago," stated Julie Fleshman, President and CEO of the Pancreatic Cancer Action Network. "As we work to double the survival rate for pancreatic cancer by 2020, we are committed to building a comprehensive and coordinated pancreatic cancer research community to speed the acquisition of knowledge, share information and move findings into practice. We look forward to partnering with this talented group of new grant recipients."

The Pancreatic Cancer Action Network-AACR Pathway to Leadership Grants are five-year grants totaling $600,000 each. These grants are designed to support the future leadership of pancreatic cancer research by funding outstanding early-career investigators beginning in their postdoctoral, mentored research positions and continuing through their successful transition to independence. The 2011 recipients are:

  • Jennifer M. Bailey, Ph.D., Johns Hopkins University School of Medicine: "Stop the Start: Novel Insights into PanIN Initiation and Progression."

  • E. Scott Seeley, M.D., Ph.D., Stanford University: "Transport Proteins as Modifiers of Oncogenic Signaling in Pancreatic Cancer."

The Pancreatic Cancer Action Network-AACR Innovative Grants are intended to promote the development and study of novel ideas and approaches in basic, translational, clinical or epidemiological research that have direct application and relevance to pancreatic cancer. These two-year grants provide $200,000 over the grant term. The 2011 recipients are:

  • Lisa A. Cannon-Albright, Ph.D., University of Utah: "Informative Linkage Analysis of High-Risk Pancreatic Cancer Pedigrees."

  • James R. Eshleman, M.D., Ph.D., Johns Hopkins University School of Medicine: "Identifying Familial Pancreatic Cancer Predisposition Genes."

  • Matthias Hebrok, Ph.D., University of California, San Francisco: "Role of miRNAs in Pancreatic Adenocarcinoma." (Grant in memory of Abby Sobrato.)

  • Hidde L. Ploegh, Ph.D., Whitehead Institute for Biomedical Research: "Generation of Transnuclear Mice from Pancreatic Cancer Infiltrating T Cells." (Grant in honor of the Kovler Family.)

The Pancreatic Cancer Action Network-AACR Career Development Awards are two-year grants of $200,000 that are designed to attract and support early-career scientists as they conduct pancreatic cancer research and establish successful career paths in the field. The 2011 recipients are:

  • Dimitrios Iliopoulos, Ph.D., Dana-Farber Cancer Institute: "Identification of Novel Molecular Circuits in Pancreatic Cancer Stem Cells."

  • Kenneth P. Olive, Ph.D., Columbia University Medical Center: "The Role of HIF1 and Hypoxia in Pancreatic Ductal Adenocarcinoma." (Grant in honor of Tempur-Pedic Retailers.)

  • Jae-Il Park, Ph.D., The University of Texas MD Anderson Cancer Center: "Telomerase in the Development of Pancreatic Cancer."

The Pancreatic Cancer Action Network-AACR Fellowship is a one-year grant of $45,000 designed to support a postdoctoral investigator's work in pancreatic cancer research. The 2011 recipient is:

  • Cosimo Commisso, Ph.D., NYU School of Medicine: "Pancreatic Cancer, Macropinocytosis and Nutrient Internalization." (Fellowship in memory of Samuel Stroum.)

In its mission to advance pancreatic cancer research, the Pancreatic Cancer Action Network has collaborated with the AACR to promote and support outstanding research focused on conquering this deadly disease. The goals of the grants program are to build a robust pancreatic cancer research community, to encourage collaboration, information-sharing and innovation, and to expedite scientific and medical breakthroughs for patient benefit.


'/>"/>

Contact: Michele Sharp
Michele.Sharp@aacr.org
267-646-0622
American Association for Cancer Research
Source:Eurekalert

Related medicine news :

1. Penn researchers uncover novel immune therapy for pancreatic cancer
2. Novel Treatment for Pancreatic Cancer Under Study
3. Malaria drug slows pancreatic cancer growth in mouse models
4. Heavy drinking associated with increased risk of death from pancreatic cancer
5. Heavy Drinking Might Raise Risk of Death From Pancreatic Cancer
6. TGen Foundation launches globalCure, targets pancreatic cancer
7. Researchers develop synthetic compound that may lead to drugs to fight pancreatic, lung cancer
8. Protein fuels inflammation in pancreatic and breast tumors
9. Everolimus improves progression-free survival for patients with rare pancreatic cancer
10. 2 Experimental Drugs Show Promise for Rare Pancreatic Cancer
11. Johns Hopkins scientists crack genetic code for form of pancreatic cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due ... up a new, often overlooked aspect of head lice: the parasite’s ability to live away ... a common occurrence, but a necessary one in the event that lice have simply gotten ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of ... too high can result in disappointment, perhaps even self-loathing. However, those who set the ... Research from PsychTests.com reveals that behind the tendency to set low expectations ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
Breaking Medicine Technology: